Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation
Science Translational Medicine · 2025
DOI: 10.1126/scitranslmed.ads9470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Sachin Sharma und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, CA 94143, USA. Hauptthemen laut MEDLINE: Extracellular Matrix, Hepatic Stellate Cells, Liver Cirrhosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIDDK NIH HHS, NIAAA NIH HHS.
Abstract (Originalsprache)
Tissue fibrosis arises from a critical imbalance between the production and breakdown of extracellular matrix (ECM) components. Whereas current strategies predominantly focus on curbing ECM production, the possibility of promoting ECM degradation to resolve fibrosis remains largely untapped. The role of hepatic stellate cells (HSCs) in ECM degradation is an intriguing area for investigation. We previously demonstrated that inhibiting acid ceramidase (aCDase) increases ceramide in HSCs to ameliorate hepatic fibrosis. Here, we uncover a key signaling pathway that promotes ECM degradation in primary human HSCs, which is dependent upon the activation of protein kinase Cα (PKCα) and the induction of matrix metalloproteinase 1 (MMP-1) through extracellular signal–regulated kinase 1/2 (ERK1/2). Genetic reduction and pharmacological inhibition with a small molecule reduced aCDase activity, leading to increased collagen degradation and hepatic fibrosis resolution in the carbon tetrachloride (CCl 4 ) and fructose, palmitate, cholesterol, and trans-fat (FPC) mouse models. Consistently, ceramide signaling correlated with ECM remodeling and degradation in patients with metabolic dysfunction–associated steatotic liver disease. The findings show that ceramide regulates ECM degradation and establish aCDase as a target for therapeutic regression of fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, CA 94143, USA.
- Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
- Division of Pulmonary, Critical Care, Allergy, and Sleep, Department of Medicine, University of California, San Francisco, CA 94143, USA.
- Center for Bioengineering and Tissue Regeneration, Department of Surgery, University of California, San Francisco, CA 94143, USA.
- Department of Pediatrics, University of California, San Francisco, CA 94143, USA.
- Innovation Ventures, University of California, San Francisco, CA 94143, USA.
ORCID-Profile: Sachin Sharma, Vijaya Prathigudupu, Lia R Serrano, Alina Chen, Ghmkin Hassan, Johnathon Lakins, Tatsuya Tsukui, Roopa Ramamoorthi, Jae-Jun Kim, Aras N Mattis, Regan F Volk, Balyn W Zaro, Joshua J Coon, William F DeGrado, Valerie M Weaver, Stephanie A Christenson, Hyunil Jo, Jennifer Y Chen
Förderung
- NIGMS NIH HHS
- NIDDK NIH HHS
- NIAAA NIH HHS
- NCI NIH HHS
- NHGRI NIH HHS
Zitieren
APA
Sharma, S., Prathigudupu, V., Cable, C., Serrano, L. R., Nerella, S., Chen, A., Hassan, G., Lakins, J., Valenzuela, C. L., Tsukui, T., Ramamoorthi, R., Kim, J. J., Willenbring, H., Mattis, A. N., Volk, R. F., Zaro, B. W., Coon, J. J., Beresis, R., DeGrado, W. F., …, & Chen, J. Y. (2025). Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ads9470
Vancouver
Sharma S, Prathigudupu V, Cable C, Serrano LR, Nerella S, Chen A, et al. Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.ads9470
BibTeX
@article{Sharma2025,
author = {Sharma, Sachin and Prathigudupu, Vijaya and Cable, Carson and Serrano, Lia R and Nerella, Srilaxmi and Chen, Alina and Hassan, Ghmkin and Lakins, Johnathon and Valenzuela, Carlos Lizama and Tsukui, Tatsuya and Ramamoorthi, Roopa and Kim, Jae-Jun and Willenbring, Holger and Mattis, Aras N and Volk, Regan F and Zaro, Balyn W and Coon, Joshua J and Beresis, Richard and DeGrado, William F and Weaver, Valerie M and Christenson, Stephanie A and Jo, Hyunil and Chen, Jennifer Y},
title = {Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation},
journal = {Science Translational Medicine},
year = {2025},
doi = {10.1126/scitranslmed.ads9470}
}
EUVIMED